Metastatic Pancreatic Cancer
| Published in: | Journal of Investigative Surgery |
|---|---|
| Main Authors: | Piotr Hogendorf, Adam Durczyński, Janusz Strzelczyk |
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2018-03-01
|
| Online Access: | http://dx.doi.org/10.1080/08941939.2017.1291774 |
Similar Items
The Role of microRNA in Pancreatic Cancer
by: Beata Smolarz, et al.
Published: (2021-09-01)
by: Beata Smolarz, et al.
Published: (2021-09-01)
FT3 to FT4 Conversion Ratio May Be an Independent Prognostic Factor in Pancreatic Cancer Patients
by: Alicja Majos, et al.
Published: (2022-12-01)
by: Alicja Majos, et al.
Published: (2022-12-01)
The concentration of D-dimers in portal blood positively correlates with overall survival in patients with non-resectable pancreatic cancer
by: Adam Durczynski, et al.
Published: (2017-12-01)
by: Adam Durczynski, et al.
Published: (2017-12-01)
Very high and very low levels of preoperative absolute monocyte count indicate poor long-term survival outcomes in patients with pancreatic adenocarcinoma. A preliminary study
by: Alicja Majos, et al.
Published: (2022-10-01)
by: Alicja Majos, et al.
Published: (2022-10-01)
Peripheral Eosinophil Count May Be the Prognostic Factor for Overall Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Surgical Treatment
by: Wojciech Ciesielski, et al.
Published: (2024-11-01)
by: Wojciech Ciesielski, et al.
Published: (2024-11-01)
Peroral endoscopic myotomy as an effective and safe treatment for achalasia: The authors’ experience and a literature review
by: Wojciech Ciesielski, et al.
Published: (2025-10-01)
by: Wojciech Ciesielski, et al.
Published: (2025-10-01)
A rare variant of ileus – Bouveret’s syndrome
by: Weronika Frąk, et al.
Published: (2022-03-01)
by: Weronika Frąk, et al.
Published: (2022-03-01)
The influence of liver and pancreas surgery on the thyroid function
by: Wojciechowska-Durczynska Katarzyna, et al.
Published: (2012-12-01)
by: Wojciechowska-Durczynska Katarzyna, et al.
Published: (2012-12-01)
Transcriptome analysis of the procession from chronic pancreatitis to pancreatic cancer and metastatic pancreatic cancer
by: Jihao Tu, et al.
Published: (2021-02-01)
by: Jihao Tu, et al.
Published: (2021-02-01)
Metastatic Pancreatic Cancer: Where Are We?
by: Abraham Hernández-Blanquisett, et al.
Published: (2024-01-01)
by: Abraham Hernández-Blanquisett, et al.
Published: (2024-01-01)
Spontaneous Splenic Rupture due to Metastatic Pancreatic Cancer
by: D. Politis, et al.
Published: (2021-01-01)
by: D. Politis, et al.
Published: (2021-01-01)
Primary and metastatic cellular landscapes in human pancreatic cancer
by: Nina G. Steele, et al.
Published: (2025-08-01)
by: Nina G. Steele, et al.
Published: (2025-08-01)
Metastatic Pancreatic Cancer: Are We Making Progress in Treatment?
by: Joanne Chiu, et al.
Published: (2012-01-01)
by: Joanne Chiu, et al.
Published: (2012-01-01)
Metastatic pancreatic cancer is dependent on oncogenic Kras in mice.
by: Meredith A Collins, et al.
Published: (2012-01-01)
by: Meredith A Collins, et al.
Published: (2012-01-01)
Pancreatic ductal adenocarcinoma in colonic wall: metastatic disease or cancerized pancreatic ectopic tissue?
by: Graziana Gallo, et al.
Published: (2020-04-01)
by: Graziana Gallo, et al.
Published: (2020-04-01)
Evaluation of selected circulating cytokines from the IL-6 family – interleukin 6, oncostatin M, and cardiotrophin-1 – in gastro-entero-pancreatic and bronchial neuroendocrine tumours
by: Janusz Strzelczyk, et al.
Published: (2024-08-01)
by: Janusz Strzelczyk, et al.
Published: (2024-08-01)
Pancreatic Carcinoma Metastatic to the Gingiva
by: Arijan Zubović, et al.
Published: (2021-01-01)
by: Arijan Zubović, et al.
Published: (2021-01-01)
Metastatic heterogeneity in pancreatic cancer: mechanisms and opportunities for targeted intervention
by: Ravikanth Maddipati
Published: (2025-07-01)
by: Ravikanth Maddipati
Published: (2025-07-01)
The Prognostic Value of the EASIX Score in Patients with Metastatic Pancreatic Cancer
by: Vahit Can Cavdar, et al.
Published: (2025-07-01)
by: Vahit Can Cavdar, et al.
Published: (2025-07-01)
Metastatic Pancreatic Cancer: Current Treatment Options for Swiss Patients
by: Sara De Dosso, et al.
Published: (2021-06-01)
by: Sara De Dosso, et al.
Published: (2021-06-01)
The role of FOLFIRINOX in metastatic pancreatic cancer: a meta-analysis
by: Beilei Zhang, et al.
Published: (2021-06-01)
by: Beilei Zhang, et al.
Published: (2021-06-01)
The Metastatic Potential and Chemoresistance of Human Pancreatic Cancer Stem Cells.
by: Vikash J Bhagwandin, et al.
Published: (2016-01-01)
by: Vikash J Bhagwandin, et al.
Published: (2016-01-01)
Metastatic Pancreatic Cancer: Current Treatment Options for Swiss Patients
by: Sara De Dosso, et al.
Published: (2021-06-01)
by: Sara De Dosso, et al.
Published: (2021-06-01)
Prolonged survival in metastatic pancreatic cancer: a case of multimodal therapy
by: Trishtha Agarwal, et al.
Published: (2025-07-01)
by: Trishtha Agarwal, et al.
Published: (2025-07-01)
Systemic Therapy for Metastatic Pancreatic Cancer—Current Landscape and Future Directions
by: Daniel Netto, et al.
Published: (2024-09-01)
by: Daniel Netto, et al.
Published: (2024-09-01)
Hyperglycemia aggravates microenvironment hypoxia and promotes the metastatic ability of pancreatic cancer
by: Wei Li, et al.
Published: (2018-01-01)
by: Wei Li, et al.
Published: (2018-01-01)
Current status on the place of FOLFIRINOX in metastatic pancreatic cancer and future directions
by: Aurélien Lambert, et al.
Published: (2017-08-01)
by: Aurélien Lambert, et al.
Published: (2017-08-01)
Dermatomal eruption as the first clinical manifestation of recurrent metastatic pancreatic cancer
by: Redina Bardhi, BS, et al.
Published: (2021-12-01)
by: Redina Bardhi, BS, et al.
Published: (2021-12-01)
Possibilities of palliative chemotherapy in patients with locally advanced and metastatic pancreatic cancer
by: L. I. Moskvicheva, et al.
Published: (2020-12-01)
by: L. I. Moskvicheva, et al.
Published: (2020-12-01)
Integrated Cancer Treatment in the Course of Metastatic Pancreatic Cancer: Complete Resolution in 2 Cases
by: Massimo Bonucci MD, et al.
Published: (2018-09-01)
by: Massimo Bonucci MD, et al.
Published: (2018-09-01)
Cost‐Effectiveness Analysis of First‐Line Chemotherapy for Metastatic Pancreatic Cancer in Japan
by: Yuriko Sasahara, et al.
Published: (2025-09-01)
by: Yuriko Sasahara, et al.
Published: (2025-09-01)
Early Celiac Plexus Block in Metastatic Pancreatic Cancer: A Case Report
by: Brian Fardman, et al.
Published: (2025-10-01)
by: Brian Fardman, et al.
Published: (2025-10-01)
Discovery of a novel RSK2 inhibitor for the treatment of metastatic pancreatic cancer
by: Chi-Hsiu Chung, et al.
Published: (2025-12-01)
by: Chi-Hsiu Chung, et al.
Published: (2025-12-01)
Metastatic pancreatic cancer now in remission: a case report and literature review
by: Charles W. Shi, et al.
Published: (2025-01-01)
by: Charles W. Shi, et al.
Published: (2025-01-01)
Prognostic value of initial and longitudinal changes in body composition in metastatic pancreatic cancer
by: Min Woo Lee, et al.
Published: (2024-04-01)
by: Min Woo Lee, et al.
Published: (2024-04-01)
The Role of Immune Checkpoint Inhibitors in Metastatic Pancreatic Cancer: Current State and Outlook
by: Linh Chi Tran, et al.
Published: (2023-10-01)
by: Linh Chi Tran, et al.
Published: (2023-10-01)
The seemingly innocuous presentation of metastatic pancreatic tail cancer: a case report
by: Milton Rahman, et al.
Published: (2019-06-01)
by: Milton Rahman, et al.
Published: (2019-06-01)
Combined Effect of and Ionizing Radiation on Survival and Metastatic Activity of Pancreatic Cancer Cells
by: Lior Hagoel, et al.
Published: (2019-03-01)
by: Lior Hagoel, et al.
Published: (2019-03-01)
Is plasma caveolin-1 level a prognostic biomarker in metastatic pancreatic cancer?
by: Nebi S Demirci, et al.
Published: (2017-01-01)
by: Nebi S Demirci, et al.
Published: (2017-01-01)
Diagnostic and therapeutic management of severe acute pancreatitis. Evidence based medicine (EBM) clinical practice guidelines
by: Jacek Szeliga, et al.
Published: (2025-04-01)
by: Jacek Szeliga, et al.
Published: (2025-04-01)
Similar Items
-
The Role of microRNA in Pancreatic Cancer
by: Beata Smolarz, et al.
Published: (2021-09-01) -
FT3 to FT4 Conversion Ratio May Be an Independent Prognostic Factor in Pancreatic Cancer Patients
by: Alicja Majos, et al.
Published: (2022-12-01) -
The concentration of D-dimers in portal blood positively correlates with overall survival in patients with non-resectable pancreatic cancer
by: Adam Durczynski, et al.
Published: (2017-12-01) -
Very high and very low levels of preoperative absolute monocyte count indicate poor long-term survival outcomes in patients with pancreatic adenocarcinoma. A preliminary study
by: Alicja Majos, et al.
Published: (2022-10-01) -
Peripheral Eosinophil Count May Be the Prognostic Factor for Overall Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Surgical Treatment
by: Wojciech Ciesielski, et al.
Published: (2024-11-01)
